VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 54 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,497,000 | +10.6% | 1,479,733 | 0.0% | 0.20% | +20.1% |
| Q2 2021 | $16,721,000 | -25.4% | 1,479,733 | 0.0% | 0.17% | -19.5% |
| Q1 2021 | $22,418,000 | +31.6% | 1,479,733 | 0.0% | 0.21% | +40.9% |
| Q4 2020 | $17,032,000 | +48.7% | 1,479,733 | 0.0% | 0.15% | +3.5% |
| Q3 2020 | $11,453,000 | -29.7% | 1,479,733 | 0.0% | 0.14% | -37.1% |
| Q2 2020 | $16,292,000 | +0.7% | 1,479,733 | 0.0% | 0.23% | -15.8% |
| Q1 2020 | $16,173,000 | -31.2% | 1,479,733 | 0.0% | 0.27% | -19.0% |
| Q4 2019 | $23,513,000 | +7.7% | 1,479,733 | 0.0% | 0.34% | -18.8% |
| Q3 2019 | $21,841,000 | +27.0% | 1,479,733 | 0.0% | 0.41% | +55.6% |
| Q2 2019 | $17,194,000 | +7.5% | 1,479,733 | 0.0% | 0.27% | +7.3% |
| Q1 2019 | $15,996,000 | +32.6% | 1,479,733 | 0.0% | 0.25% | +11.2% |
| Q4 2018 | $12,060,000 | -49.8% | 1,479,733 | 0.0% | 0.22% | -23.1% |
| Q3 2018 | $24,046,000 | -17.6% | 1,479,733 | 0.0% | 0.29% | -16.7% |
| Q2 2018 | $29,195,000 | – | 1,479,733 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |